$22.01
0.401.85%
마지막 업데이트: Oct 29, 4:00 PM
Benzinga
Benzinga
Benzinga
목요일, 10월 29
Benzinga
© 2026 Benzinga | All Rights Reserved
Damora Therapeutics (DMRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.56 | $-0.12 | — |
| Actual | $-0.39 | $-0.62 | $2.90 | $-2.36 |
| Surprise | -5.41% | -10.7% | +2516.7% | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.45 | $-0.48 | $-0.48 | $-0.50 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.39 | $-0.37 | -5.41 % |
| Q1 | May 12, 2026 | $-0.62 | $-0.56 | -10.7 % |
| Q4 | Mar 19, 2026 | $2.90 | $-0.12 | 2516.7 % |
| Q4 | Mar 19, 2025 | $-5.23 | $-2.82 | -85.5 % |